Sunday 14 December | 20:47:47 Europe / Stockholm

Calendar

Est. time*
2026-10-29 07:00 Quarterly Report 2026-Q3
2026-07-10 07:00 Quarterly Report 2026-Q2
2026-04-30 07:00 Quarterly Report 2026-Q1
2026-04-28 N/A Annual General meeting
2026-02-12 08:00 Year-end Report 2025
2025-10-31 - Quarterly Report 2025-Q3
2025-07-11 - Quarterly Report 2025-Q2
2025-04-30 - Quarterly Report 2025-Q1
2025-04-28 - Ex-date Ordinary Dividend AKBM 0.00 NOK
2025-04-25 - Annual General meeting
2025-02-12 - Year-end Report 2024
2024-11-01 - Quarterly Report 2024-Q3
2024-09-09 - Ex-date Ordinary Dividend AKBM 45.00 NOK
2024-09-03 - Extra General Meeting 2024
2024-07-12 - Quarterly Report 2024-Q2
2024-04-26 - Quarterly Report 2024-Q1
2024-04-17 - Ex-date Ordinary Dividend AKBM 0.00 NOK
2024-04-16 - Annual General meeting
2024-02-14 - Year-end Report 2023
2023-11-01 - Quarterly Report 2023-Q3
2023-07-14 - Quarterly Report 2023-Q2
2023-04-28 - Quarterly Report 2023-Q1
2023-04-21 - Ex-date Ordinary Dividend AKBM 0.00 NOK
2023-04-20 - Annual General meeting
2023-02-15 - Year-end Report 2022
2022-11-01 - Quarterly Report 2022-Q3
2022-07-14 - Quarterly Report 2022-Q2
2022-04-29 - Quarterly Report 2022-Q1
2022-04-21 - Ex-date Ordinary Dividend AKBM 0.00 NOK
2022-04-20 - Annual General meeting
2022-02-17 - Year-end Report 2021
2021-10-29 - Quarterly Report 2021-Q3
2021-07-14 - Quarterly Report 2021-Q2
2021-04-29 - Quarterly Report 2021-Q1
2021-03-15 - Ex-date Ordinary Dividend AKBM 0.00 NOK
2021-03-12 - Annual General meeting
2021-02-16 - Year-end Report 2020
2020-10-30 - Quarterly Report 2020-Q3
2020-07-15 - Quarterly Report 2020-Q2

Description

CountryNorway
ListOslo Bors
SectorTrading & Goods
IndustryDagligvaror
Aker BioMarine operates in biotechnology. The company specializes in the development of dietary supplements. The product portfolio is broad and includes, for example, omega-3 oil, nutritional supplements for animals, and protein supplements for fish farming. The business is operated globally with the largest presence in the Nordic market. Customers consist of both private players and wholesalers. Aker BioMarine was founded in 2006 and is headquartered in Oslo.

Interested in the company’s key figures?

Analyze the company in Börsdata!

Who owns the company?

Find all ownership data in Holdings!

2024-03-20 08:00:00
20 March 2024: The annual general meeting of Aker BioMarine ASA will be held on
Tuesday 16 April 2024 at 13:00 CET.

The meeting will be conducted as a virtual meeting only, and voting will be
handled online during the meeting. Information about log-in details for the
meeting is available in the notice of
the general meeting. For further information regarding participation, please go
to www.akerbiomarine/agm.

No pre-registration is needed for attending online, but attendees must be logged
in before the meeting starts. Deadline for registration of advance votes and
proxies is 15 April 2024 at 16:00 CET.

Please find attached the following documents
- Notice and Proxy forms for the Annual General Meeting 2024
- Proposed Resolutions for the Annual General Meeting 2024
- Remuneration Report 2023
- Proposal from the Nomination Committee

All documents to be processed in the meeting are available on
www.akerbiomarine/agm.

For further information, please contact
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.

About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.